Menopause
<乌鸦传媒 class="page-description">More in Menopause
The warning highlights known risk of rare but serious liver injury associated with fezolinetant
Selected highlights from the 2024 American College of Gastroenterology annual meeting
Also in TTHealthWatch: menopause hormone therapy in the U.S.
Survey indicates persistent pain and re-intervention may play a role
Cognitive behavioral therapy tied to better satisfaction and desire
E4Comfort II trial also found improvements in quality of life and markers of bone health
No association between earlier violence and processing speed, verbal memory
No adverse liver effects seen with elinzanetant in OASIS 3 trial
Meta-analysis of 23 randomized trials showed lower HOMA-IR
Despite renewed spotlight on menopause, use by insured still hasn't rebounded
Clinicians should perform liver blood tests before and during Veozah treatment
Also in TTHealthWatch: myocarditis after COVID vaccination
But further investigations capable are warranted to confirm the findings, researcher says
Skeletal characteristics may not be to blame among older women
